CD19 status matters: defining treatment options in refractory and relapsed B-ALL

Authors

• Caitlin M. Sullivan, LSU Health Sciences Center - New OrleansFollow
• Casey M. Treuting, Tulane School of Medicine, New Orleans, LAFollow
• Justin Farge, Tulane School of Medicine, New Orleans, LAFollow
• Zachary Leblanc, Tulane School of Medicine, New Orleans, LAFollow

Document Type

Conference Proceeding

Publication Date

2-13-2026

Publication Title

The American Journal of the Medical Sciences

Abstract

2026 Southern Regional Meeting, February 26–28, 2026, New Orleans, LA

First Page

S170

Volume

371

Issue

Supplement 1

Comments

Abstract #275

Rights

© 2025 Published by Elsevier Inc.

Recommended Citation

Sullivan, Caitlin M.; Treuting, Casey M.; Farge, Justin; and Leblanc, Zachary, "CD19 status matters: defining treatment options in refractory and relapsed B-ALL" (2026). School of Medicine Faculty Publications. 5112.
https://digitalscholar.lsuhsc.edu/som_facpubs/5112
10.1016/j.amjms.2025.12.280